Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

INFI

Infinity Pharmaceuticals (INFI)

Infinity Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INFI
DatumZeitQuelleÜberschriftSymbolFirma
13/09/202314h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
13/09/202300h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INFIInfinity Pharmaceuticals Inc
11/09/202322h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
01/09/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
10/08/202322h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INFIInfinity Pharmaceuticals Inc
25/07/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
25/07/202322h05Business WireInfinity Pharmaceuticals Announces Value Preservation and Maximization PlanNASDAQ:INFIInfinity Pharmaceuticals Inc
24/07/202314h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
24/07/202314h30Business WireInfinity Pharmaceuticals Announces Termination of Merger Agreement with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
14/07/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
14/07/202319h00Business WireInfinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202314h30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202314h30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202314h30Business WireInfinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)NASDAQ:INFIInfinity Pharmaceuticals Inc
05/07/202314h30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
05/07/202314h30Business WireISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.NASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202322h57Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202322h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202314h31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
30/06/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
29/06/202312h01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
27/06/202314h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
21/06/202314h32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
20/06/202314h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
20/06/202314h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INFIInfinity Pharmaceuticals Inc
16/06/202318h34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
16/06/202314h32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
15/06/202318h08Business WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
15/06/202314h00Business WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
06/06/202322h44Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INFI

Kürzlich von Ihnen besucht